NasdaqGM:HRMYPharmaceuticals
How Investors May Respond To Harmony Biosciences (HRMY) Strengthening Its C-Suite And Board For Execution
Harmony Biosciences recently appointed industry veteran Peter Anastasiou as Senior Executive Vice President and Chief Operating Officer, while reshaping its board with the addition of finance specialist Troy Ignelzi and the nomination of long-time pharmaceutical leader Geno J. Germano for election at the 2026 Annual Meeting.
By shifting Anastasiou from the board into an operational role and adding Ignelzi’s capital markets expertise, the company is tightening the link between governance,...